intelligence360
  • SUBSCRIBE
  • About us
  • Video News Daily
  • Contact Us
  • Search Icon

intelligence360

The Intelligent News Source

Colossal Advances Dodo De-Extinction with Significant, World’s First Breakthrough in Pigeon PGCs and Secures an Additional $120M in Funding for Species Expansion

Colossal Advances Dodo De-Extinction with Significant, World’s First Breakthrough in Pigeon PGCs and Secures an Additional $120M in Funding for Species Expansion

September 30, 2025 Craig Etkin

Groundbreaking achievements include successfully grown Pigeon Primordial Germ Cells (PGCs), gene edited chicken surrogates, three new avian genomes for key dodo comparison species, the creation of a breeding colony of Nicobar pigeons in Texas, and the formation of the Mauritius Dodo Advisory Committee to guide conservation and rewilding

DALLAS–(BUSINESS WIRE)–Colossal Biosciences, the world’s de-extinction company, today announces several milestones in avian cellular science, bringing the dodo revival one step closer. The Colossal Avian Genetics Group has successfully grown pigeon primordial germ cells (PGCs) for the first time in history, a pivotal step in bringing back the dodo. In addition to this breakthrough, Colossal has also announced an additional expansion of $120M in new funding with participation from USIT, Bob Nelsen, and Peter Jackson adding to its $200M Series C, bringing this round of capital to $320M. Since launching in September 2021, Colossal has raised just over $555M in total funding. This latest round of capital places the company at a $10.32 billion valuation.

On the heels of the Moa de-extinction announcement, the funding allows for the expansion of Colossal’s Avian Genetics Group who also have established a flock of gene-edited chickens that will serve as potential surrogates for dodos and other endangered bird species and generated new genomic resources for exotic and endangered pigeons that will facilitate identification of editing priorities for the dodo de-extinction project. These advances significantly accelerate progress toward dodo de-extinction and broaden tools for advancing biodiversity conservation for birds. The advances Colossal has made now extend avian PGC culture technology beyond chicken and geese, opening a new frontier in avian reproductive science.

Colossal has also announced the formation of the Mauritius Dodo Advisory Committee, a board of qualified individuals with deep connections to the country’s culture. The experts will continue to provide input on Colossal’s local conservation efforts and aid in the development of a dodo rewilding program in Mauritius.

“Our avian team’s breakthrough in deriving culture conditions that allow pigeon primordial germ cells to survive long-term is a significant advancement for dodo de-extinction,” shared Colossal CEO and co-founder Ben Lamm. “This progress highlights how Colossal’s investment in de-extinction technology is driving discovery and developing tools for both our de-extinction and conservation efforts. Following the global excitement around our recent moa announcement, this new infusion of capital will help us expand our infrastructure and grow our avian genomics team to accelerate not only the new moa de-extinction project, but also continue to track progress on the dodo.”

Surmounting the PGC Roadblock

The path to de-extinction of any species includes transforming an edited cell into a living organism. For mammals, this process involves somatic cell nuclear transfer, which is commonly known as “cloning.” Because of the large size and opacity of avian eggs and because they are laid after the embryo starts to develop, it is not currently possible to clone birds, which require a different technology in order to pass genetic modifications on to the next generation. This path involves culturing and editing primordial germ cells (PGCs), which can then become the sperm and eggs used to produce the next generation of birds. By fertilizing modified eggs with modified sperm, the gene edits are passed to the next generation.

Until this milestone achievement by Colossal’s avian team, PGC culture was only possible for chickens and geese, limiting the application of genome engineering technologies in birds. Today, Colossal announces a breakthrough in PGC culture for pigeons, paving the way to create the world’s first dodos in nearly three hundred years.

“The first cell culture recipe was for chicken PGCs, and was published nearly 20 years ago,” said Anna Keyte, Avian Species Director. “Unfortunately, that recipe has not worked on any other bird species tested, even closely related species like quail. Colossal’s discovery of a recipe for pigeons dramatically expands avian reproductive technologies and is the foundation for our dodo work.”

To develop the pigeon PGC culture protocol, the avian team tested more than 300 combinations of growth factors, small molecules, and metabolites. The PGCs have now been growing for more than two months with a doubling rate of 35 hours. The cultured cells successfully migrate to the gonads when injected into surrogate embryos, confirming that they behave as PGCs. The team is banking these cells and will use them to apply the company’s genetic engineering strategies for pigeon PGCs. Details of the research were published today as a preprint on bioRxiv and submitted for peer review.

Beyond de-extinction applications, PGC culture opens new conservation pathways for endangered species like the Mauritian pink pigeon, which has suffered population bottlenecks and genetic diversity loss. The technology enables restoration of lost genetic variation using museum specimen data, engineering of disease-resistant cell lines, and biobanking as insurance against future genetic losses.

“This breakthrough in culturing pigeon primordial germ cells represents a transformative tool for avian conservation,” said Beth Shapiro, Colossal’s Chief Science Officer. “By developing these protocols, we’re establishing crucial biobanking capabilities and opening new possibilities for genetic rescue of endangered species.”

A Colossal Colony of Gene-Edited Birds

Generating edited PGCs is only the first step of a two-step process to create genetically modified birds. To create a genetically modified bird, edited PGCs are injected into developing chick embryos, where the PGCs continue to develop into functional eggs and sperm. When those chicks hatch, they will be chimeric: their sperm or eggs will contain the intended edits, but the rest of the cells in their bodies will contain unmodified genomes. When they reach sexual maturity, these edited sperm and eggs can be fused via normal or artificial fertilization, resulting in genetically edited birds.

While this process sounds simple, few labs in the world have achieved production of chicks with gene-edited germ cells in their gonads. Today, Colossal also announces that it has achieved this success, and done so within less than six months of establishing the company’s avian colony.

Colossal is using the Nicobar pigeon, the closest living relative of the dodo, as the donor genome for de-extinct dodos. They established a colony of breeding Nicobar pigeons in Texas that have started laying eggs and, from those embryos, the team has established fibroblast cultures for test editing and collected the first Nicobar PGCs. These PGCs will be grown using Colossal’s newly described pigeon PGC culture media. Colossal and its network of partners have already applied for and been granted all necessary US permits and approvals for the import and export of biological samples and specimens needed for this project.

At the same time, Colossal is gene-editing chickens so that they don’t make their own germ cells. To make a dodo, the avian team will inject edited Nicobar pigeon PGCs into these developing chicks, so that they carry pigeon germ cells rather than chicken germ cells. This means a chicken could eventually lay an egg that hatches into a pigeon. Together, these advances – pigeon PGC culture and gene-edited chickens that do not make their own PGCs – set the stage for using surrogate chickens to help bring back dodo relatives, and eventually the dodo itself.

New High Quality Avian Genomes Improve Dodo-specific Variants

With the system to engineer a dodo now realized, the avian team is also announcing new resources to allow the discovery of dodo-specific genomic traits: the genetic edits that will transform the Nicobar pigeon genome into the dodo genome. Specifically, the team is announcing the generation of high quality genome sequences for three species: the tooth billed pigeon (or manumea), Rodrigues solitaire, and Nicobar pigeon.

The tooth-billed pigeon, or little dodo, is a critically endangered bird that is closely related to the dodo. Restricted to forested regions in Samoa, it is considered a lost species, with the last confirmed photo taken in 2013. In partnership with the University of California Santa Cruz Paleogenomics Lab and Harvard University Museum of Vertebrate Zoology, Colossal’s Avian Genomics Group sequenced and assembled a reference genome for the tooth billed pigeon from a preserved skin sample.

Colossal’s avian team also generated a 10-fold coverage genome from a Rodrigues solitaire, an extinct flightless bird that is a sister species to the dodo. Dodos were endemic to Mauritius Island, and solitaires were only ever found on neighboring Rodrigues Island. The two species shared a common ancestor approximately 7 million years ago.

“The solitaire was a large flightless bird that was similar in many ways to the dodo but also behaviorally and physically distinct,” said paleontologist Julian Hume of the Natural History Museum in London and Tring, who collected the samples from cave sites on Rodrigues. “Colossal’s genome will allow new insights into the genetic reasons underlying the differences between these birds and highlight what DNA sequences made the dodo distinct.”

Colossal’s team also produced a new chromosome-scale genome for the Nicobar pigeon using a combination of short- and long-read sequencing technologies, resulting in the highest quality Nicobar pigeon genome available. This genome is available for download from the NCBI database and the description of the sequencing and assembly process has been peer reviewed and published in the Journal of Heredity.

“Like the advances the team has made in avian reproductive technologies, these genomic resources will have far-reaching implications for our work and for the work of others,” said Anna Keyte. “The genomic data will help us learn why each of these birds are unique, making it possible for us to prioritize our gene editing but also helping us to understand what we’re losing as bird species become increasingly rare and possibly extinct.”

Colossal forms Mauritius Dodo Advisory Committee

As part of its partnership with Mauritius, Colossal has established the Mauritius Dodo Advisory Committee, composed of cultural, commercial, government, and community leaders with strong local ties and expertise. Meeting quarterly, the Committee provides input on Colossal’s conservation efforts, addresses community needs and concerns, and guides the development of a safe and successful dodo rewilding program.

Devina Lobine, Ph.D., the Chair of the MDAC, Research Officer, Mauritius Institute of Biotechnology said, “Driven by a deep passion for scientific discoveries and inspired by the dream of seeing the dodo walk the earth once more, I am pleased to lead the Mauritius Dodo Advisory Committee. This journey is more than reviving a lost species–it is about honouring our island’s unique heritage.” Lobine will help lead discussions focused on updates from Colossal related to genomics research, biodiversity, environmental restoration, and the long-term wellbeing of the Mauritian community.

The Mauritius Advisory Committee is made up of the following advisors:

Dr. Devina Lobine, Research Officer at the Mauritius Institute of Biotechnology & Global Leader in Science, Policy, and Innovation and Chair of the Mauritius Advisory Committee
Prof. Carl Jones, PhD, Chief Scientist, Durrell Wildlife Conservation Trust & 2016 Indianapolis Prize Laureate
Ananda Devi, Officier des Arts et des Lettres (France), Grand Officer of the Star and Key of the Indian Ocean (Mauritius), Neustadt Prize Laureate
Joya Bhandari, Environmental Consultant & Green Policy Advisor for Island Sustainability
Kallyanee Bodha, Chemistry Educator | Author | Advocate for Conservation
Dr. Dhanjay Jhurry, GOSK, CSK, Managing Director of Uniciti International Education Hub
Kevin Ramkaloan, CEO of Business Mauritius & Economic Policy Leader
Mehul Bhatt, Head of Strategy, Savanne Life Sciences & Board Director, Business Mauritius
Dr. Vidushi Neergheen, Director of the Doctoral School, University of Mauritius & Leading Researcher in Biopharmaceutical Innovation
Krishna Pentayah, Science Diplomat, Researcher, Mechanical Engineer, Climate & Cultural Leader, Author, Artist
Meiya Gujjalu, Conservation Student & Co-Founder of Daring Dodos
Vikash Rupear, Director, Natural History Museum of Mauritius
Vikash Tatayah, Director of Conservation, Mauritian Wildlife Foundation
Below is a full list of Colossal’s Avian Genetics Group scientific breakthroughs on the dodo project.

Cell Biology and Engineering:

Successfully grown pigeon primordial germ cells (PGCs) in culture for multiple weeks and they maintain important characteristics of germ cells, indicating they are healthy PGCs. Doubling rate is approximately 35 hours.
Created chickens carrying edited PGCs that have reached sexual maturity and are laying eggs. We have begun to screen offspring and have identified our first fully gene-edited birds! At sexual maturity, these chickens will lay sterile surrogate host eggs, which we will test for their ability to support the growth and development of pigeon PGCs.
Nicobar pigeons in Colossal’s Texas facility have begun to lay eggs. We have collected embryonic fibroblasts and are currently generating a cell line in which we can perform test edits. From these same embryos, we have also collected our first Nicobar PGCs.
Developed media conditions for growth of embryonic stem cells (ESCs) of pigeon, emu and tinamou. We have healthy looking ESC colonies growing and are now working to verify that they are true ESCs. ESCs can potentially be used to generate gene edited birds, as an alternative to PGCs.
Used the stable PGC colonies to edit pigeon DNA sequences with targets from the company’s computational biology work on the dodo genome. Currently, the team is working with PGCs from rock doves.
Expanded the team’s work with PGCs from Nicobar pigeon embryos, which, as the closest living relative to the dodo, will serve as the genomic surrogate for the dodo de-extinction work.
Used in ovo electroporation to target editing constructs to neural crest cells, the primary cell population that makes up a bird’s beak. We tested dodo variants to identify which genetic changes were most critical for the formation of the dodo’s unique beak and face.
Optimized delivery of editing components to avian PGCs, ensuring the highest possible cell survival following editing.
Established a new protocol for cryopreserving cells from feather pulp. This will provide conservationists with a new tool to biobank avian cells in the field and safely transport them long distances.
Genomics and Computational Biology:

Generated high quality reference genomes for Goura (a close living relative of the dodo), quail (a species we are using for development studies), and Nicobar pigeon (closest living relative of the dodo). This is in addition to the genomes we have already generated for Nicobar pigeon, Manumea (Tooth-billed pigeon), and Rodrigues Solitaire.
Curated CT scans of 75 bird skulls, matched with high quality genomes, that will be used to query which genes are most important in the development of beak and face shape.
Completed collection of hundreds of individual samples of craniofacial tissues from three different areas of the face for four species of birds (chicken, duck, quail and pigeon) across six embryonic developmental stages. These are currently being sequenced to detect regions of open chromatin (ATAC-Seq) and gene expression (RNA-Seq). The data will be used to determine the roles of different genes in beak development. As with the analysis of the bird skull scans, this information will be used to filter dodo variants for editing.
Generated a pangenome of the Dodo and its close relatives.
Analyzed the dodo genome, pinpointing regions responsible for key phenotypes.
Built a comprehensive Google Bigquery database that integrates analyses, genome annotations, and functional data to rank and prioritize dodo variant edits.
Identified flightlessness-related gene candidates for editing.
Completed single-cell RNA-seq analyses of PGCs to identify best cell culture conditions across species.
ABOUT COLOSSAL

Colossal was founded by emerging technology and software entrepreneur Ben Lamm and world-renowned geneticist and serial biotech entrepreneur George Church, Ph.D., and is the first to apply CRISPR technology for the purposes of species de-extinction. Colossal creates innovative technologies for species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. Colossal is accepting humanity’s duty to restore Earth to a healthier state, while also solving for the future economies and biological necessities of the human condition through cutting-edge science and technologies. To follow along, please visit: www.colossal.com.

WEBSITE & SOCIALS

Websites: www.colossal.com
Instagram: ​​https://www.instagram.com/colossal/
YouTube: https://www.youtube.com/@colossal
Twitter: https://x.com/colossal
LinkedIn: https://www.linkedin.com/company/colossal/
Facebook: https://www.facebook.com/itiscolossal
TikTok: https://www.tiktok.com/@colossal
BlueSky: https://bsky.app/profile/itiscolossal.bsky.social

Contacts
COLOSSAL PRESS CONTACTS:
Emily@Colossal.com

(c)2025 Business Wire, Inc., All rights reserved.


Venture Capital
Business Wire, Colossal Biosciences, Dallas, Texas, Venture Capital

Post navigation

NEXT
AmplifAI Raises $33.7M to Power High-Performing Human Teams and AI Agents Driving the Future of Customer Experience
PREVIOUS
Omni Design Technologies Secures over $35 Million in Series A Funding to Advance Its Leadership in Wideband Signal Processing™ for the AI Data Revolution
Comments are closed.
Subscribe for FREE!

Source: http://go.intelligence360.io/ and https://intelligence360.news/

Fabric, a leader in care delivery and consumer experience, has announced the acquisition of UCM Digital Health (UCM), a leading digital health and telehealth provider. The acquisition expands Fabric's services to about 400 new employer and payer customers, adding one million covered lives. Fabric now serves over 75 health systems, 30,000 employers, and over 100 million lives across all 50 states. This marks Fabric’s fifth acquisition in less than three years, underscoring its strategic build-and-buy approach to unify the fragmented digital health landscape. By expanding its footprint in the payer and employer markets, Fabric is extending its comprehensive care access and experience platform paired with its nationwide provider network to streamline virtual-first care, expand access, improve efficiency and outcomes, and reduce both medical and overhead costs.

In a statement Aniq Rahman, CEO and Founder of Fabric said, "For Fabric, it’s about making healthcare more accessible.” “We’ve already made meaningful progress in the payer and employer markets, and this acquisition allows us to deepen that impact. By bringing more payers and employers onto our platform, we’re creating a connected experience that streamlines workflows, reduces friction and costs, and ultimately drives better outcomes for members and our partners." Moving forward, the 400 payers and employers served by UCM will transition to Fabric’s expanded technology and clinical network, gaining access to enhanced omnichannel patient experiences that improve efficiency before, during, and after virtual care. Through Fabric’s nationwide provider network, patients can receive a treatment plan for most common medical conditions in just five minutes or connect with a behavioral health provider within three days.

Fabric is a health tech company on a mission to solve healthcare’s access problem. Fabric’s integrated care platform offers personalized guidance, streamlines workflows, and unifies experiences across virtual and in-person care. Its solutions support care delivery from a patient’s first search to post-treatment follow-up using its proprietary Hybrid AI that combines conversational AI and physician-built clinical logic. Together with a nationwide network of medical and behavioral health providers, Fabric is realizing its vision of providing care for everyone, everywhere. The company advances connected delivery that improves access, outcomes, and equity across every stage of the patient journey. Today, Fabric serves 30,000 employers, payers, and enterprise organizations, including OSF HealthCare, MUSC Health, Highmark, and Intermountain Health. Fabric is backed by General Catalyst, Thrive Capital, GV (Google Ventures), Salesforce Ventures, Vast Ventures, BoxGroup, and Atento Capital.
Source: http://go.intelligence360.io/ and https://intelligence360.news/

Flex has closed a $60 million Series B equity round led by Portage, bringing total equity raised to $105 million. In the last year, the company has quadrupled revenue and tripled its payments volume to $3 billion as it scales its all-in-one business and personal finance platform for high-net-worth middle-market business owners. Running a profitable middle-market business has become one of the most complex financial jobs in America, with owners often juggling more than ten disconnected systems to manage their money. Flex was created to give these high net worth owners a single place to run both their business and personal finances. This latest $60 Million equity round, followed by its $200 Million debt and $25 Million equity raise announced earlier this year, builds on a period of rapid hypergrowth. In just 12 months, Flex has grown revenue fourfold and increased annualized total payments volume from $1 billion to $3 billion across a suite of products, positioning Flex as one of the fastest-growing fintech companies at scale with best-in-class capital efficiency.

Flex is building the category-defining company solving this gap for high net worth business owners with a five-pillar strategy built around private credit, a business finance stack, a personal finance stack, payment solutions, and an ERP built for middle market businesses. These customers now use an average of four or more Flex products. Flex’s Business Credit Card, which provides 60-day float on every transaction, has been a major driver of adoption, acting as the wedge into deeper financial operations. Once owners experience the benefits of the Flex Credit Card, they often go on to adopt Flex’s banking, payments, working capital, and expense management tools to replace fragmented legacy systems. This integrated model has allowed Flex to scale with high efficiency and has created a strong foundation for its expansion into personal finance.

Launched in 2023, Flex a Flexbase Technologies brand is the AI Native “Private Bank” for high net worth business owners in the middle market. Flex is building the category-defining company solving this gap for high net worth business owners with a five-pillar strategy built around private credit, a business finance stack, a personal finance stack, payment solutions, and an ERP built for middle market businesses. Flex is the first platform that supports every step of their financial lives, from the moment they earn revenue to the moment they spend it personally.
Source: http://go.intelligence360.io/ and https://intelligence360.news/

Across the United States, a new industrial age is taking shape. Trillions of dollars in infrastructure, from energy projects and advanced manufacturing to data centers and critical mineral facilities, must be built in the next decade. But large construction projects are slower and more expensive today than they were half a century ago. Unlimited Industries, a California-based company using AI to rethink how infrastructure gets built, has raised $12 million in seed funding to change that. The round was co-led by Andreessen Horowitz and CIV, with participation from leading industry investors. The capital will accelerate Unlimited’s expansion and further develop its proprietary AI platform – one designed to make large-scale engineering and construction faster, cheaper, and more ambitious.

Unlike traditional construction firms or standard software companies, Unlimited is an AI-native construction company that both designs and builds. Its proprietary platform can generate and evaluate hundreds of thousands of design configurations in parallel, automatically identifying optimal layouts for cost, safety, and performance before construction begins. By integrating AI-driven design with its own vertically integrated engineering and construction teams, Unlimited eliminates the costly handoffs and misaligned incentives that have defined the industry for decades.

In a statement Alex Modon, Co-Founder and CEO of Unlimited Industries said, “Advances in AI mean we can finally build the physical world the way we build software.” “The traditional construction model is slow, brittle, and fundamentally misaligned. Our approach replaces static design choices with a dynamic, data-driven process that learns from every project. The result is faster, cheaper, and more successful projects.”

Unlimited is an AI-native construction company headquartered in San Francisco. Today, the company designs and builds across energy infrastructure, data centers, critical minerals, and advanced manufacturing, helping developers build with greater speed, ambition, and efficiency. Their mission is to build a future of radical physical abundance by automating construction end-to-end. The company was founded in 2025 by serial founders Alex Modon, Jordan Stern, and Tara Viswanathan.
Subscribe

Categories

Recent Posts

  • Opus’ Tollway Corporate Center in North Aurora Achieves Full Lease-Up with 408,176-SF Commitment from US Elogistics Service Corp March 18, 2026
  • Harris Health System to spend $3,600,000.00 to occupy 8,238 square feet of space in Houston Texas. March 18, 2026
  • Mergers and Acquisitions (M&A): MCF Advisors Acquires Wealth Planning Corporation March 18, 2026
  • Mergers and Acquisitions (M&A): EVI Industries, Inc. (NYSEAM: EVI) Completes Acquisition of Belenky March 18, 2026

Archives

© 2026   Copyright SI360 Inc. All Rights Reserved.